Raffles Medical Group Ltd
RAFLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $751,564 | $708,032 | $822,916 | $723,791 |
| % Growth | 6.1% | -14% | 13.7% | – |
| Cost of Goods Sold | $265,426 | $392,097 | $126,556 | $143,270 |
| Gross Profit | $486,138 | $315,935 | $639,981 | $580,521 |
| % Margin | 64.7% | 44.6% | 77.8% | 80.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $136,730 | $103,915 | $0 |
| SG&A Expenses | $0 | $142,438 | $103,915 | $41,648 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $403,644 | $57,742 | $100,731 | $416,072 |
| Operating Expenses | $403,644 | $200,180 | $204,646 | $457,720 |
| Operating Income | $82,494 | $115,755 | $195,846 | $121,306 |
| % Margin | 11% | 16.3% | 23.8% | 16.8% |
| Other Income/Exp. Net | $4,468 | $3,684 | -$4,111 | -$5,722 |
| Pre-Tax Income | $86,962 | $119,439 | $191,704 | $115,584 |
| Tax Expense | $24,680 | $28,349 | $48,002 | $31,868 |
| Net Income | $62,243 | $90,150 | $143,214 | $84,171 |
| % Margin | 8.3% | 12.7% | 17.4% | 11.6% |
| EPS | 0.034 | 0.049 | 0.077 | 0.045 |
| % Growth | -30.9% | -37.3% | 71.4% | – |
| EPS Diluted | 0.033 | 0.048 | 0.077 | 0.045 |
| Weighted Avg Shares Out | 1,857,488 | 1,859,431 | 1,857,199 | 1,867,547 |
| Weighted Avg Shares Out Dil | 1,860,824 | 1,868,552 | 1,866,347 | 1,876,460 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,247 | $9,762 | $2,740 | $634 |
| Interest Expense | $5,779 | $6,078 | $6,882 | $6,356 |
| Depreciation & Amortization | $43,088 | $24,712 | $39,130 | $39,326 |
| EBITDA | $135,829 | $132,890 | $235,870 | $161,266 |
| % Margin | 18.1% | 18.8% | 28.7% | 22.3% |